Categories
Value in Health

Primary and Secondary Healthcare Resource Use and Associated Costs in People with Hepatic Encephalopathy in England

Holden S E, Morgan, C L, Murphy D, Currie C J. 01 Nov 2019

Categories
Value in Health

Patterns of Estimated Glomerular Filtration Rate and Albuminuria in Relation to Progression to Serious Outcomes: Hospitalization for Infection, Major Adverse Cardiovascular Events and Renal Failure

Pritchard N, Jenkins-Jones S, Berni E R, Jermutus L, Jain M, Ambery P, Currie C J. 01 Oct 2017

Categories
Value in Health

The Burden of Illness of Congenital Adrenal Hyperplasia In The United Kingdom: A Retrospective, Observational Study

Jenkins-Jones S, Whitaker M J, Holden S E, Morgan C L, Ross R J M, Currie C J. 01 Nov 2015

Categories
Value in Health

Association of Adverse Events And Health Service Usage With Tapentadol Prolonged-Release Treatment Compared With Morphine Controlled-Release (Cr) And Oxycodone Cr: A Uk Primary Care Observational Study

Baxter G Morgan C L, Jenkins-Jones S, Currie C J, Schultewolter D. 01 Nov 2015

Categories
HCRU Value in Health

Evaluation of The Cost Effectiveness and Societal Impact of Rifaximin-α 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In The Netherlands

Whitehouse J T, Berni E R, Conway P, Radwan A, Henrar R, Currie C J. 01 Nov 2015

Categories
Value in Health

Evaluation of The Cost Effectiveness of Rifaximin-α In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium

Berni E R, Connolly M, Conway P, Radwan A, Currie C J. 01 Nov 2015

Categories
Value in Health

Automatic development of clinical prediction models with genetic programming: A case study in cardiovascular disease

Bannister Ch A, Currie C J, Preece A, Spasic I. 01 May 2014

Categories
Value in Health

Difficulty in establishing the impact of drugs on quality of life in cognitively impaired patients: Example of attempting to derive utility in patients treated with rifaximin-α for the reduction of recurrence of episodes of hepatic encephalopathy

Berni E R, Conway P, Nanuwa K, Currie C J. 01 May 2014

Categories
Value in Health

Treatment Of Neuropathic Pain With The Capsaicin 8% Patch Qutenzatm: Evaluation Of Time To Retreatment, Patch Usage And Pain Alleviation

Chambers C, Poole C D, Berni E R, Odeyemi I, Thomas R, Currie C J. 01 May 2014

Categories
Value in Health

The impact of concomitant metformin on mortality and other serious outcomes in people with type 2 diabetes treated with insulin

Holden S E, Currie C J. 01 May 2014

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

MEET OUR BRANDS

About HDS

  • Our company
  • Boilerplate copy

HUMAN DATA SCIENCE

Logo
  • The HDS Logo
  • Logo mark
  • Clearspace
  • Backgrounds
Colours
  • Primary Palette
  • Secondary Palette

LIVINGSTONEIQ

Logo
  • The Livingstone Logo
  • Logo mark
  • Clearspace
  • Backgrounds
Colours
  • Primary Palette
  • Secondary Palette

PREVALENCEUK

Logo
  • The PrevalenceUK Logo
  • Logo mark
  • Clearspace
  • Backgrounds
Colours
  • Primary Palette
  • Secondary Palette

TYPOGRAPHY

  • Typestack

VOICE AND TONE

ICONS

  • Icon basics
  • Design considerations
  • Icon styles